Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users

Trial Profile

Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2015

At a glance

  • Drugs Tenofovir (Primary) ; Ethinylestradiol/levonorgestrel; Medroxyprogesterone
  • Indications Hepatitis B; HIV infections; Pregnancy
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors CONRAD
  • Most Recent Events

    • 09 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 Dec 2013 Planned end date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
    • 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top